CN Patent

CN102078285A — 含有皮质激素和h1受体拮抗剂的鼻用原位凝胶

Assigned to Tianjin Jinyao Group Co Ltd · Expires 2011-06-01 · 15y expired

What this patent protects

含有皮质激素和H1受体拮抗剂的鼻用原位凝胶，由作为有效成分由一种或几种皮质激素和一种或几种H1受体拮抗剂、环境敏感型亲水凝胶材料、其它药剂学上可接受的辅料以及余量的水制成，制剂的组分组成为：皮质激素0.01-1％，H1受体拮抗剂的含量为0.05％～1％，环境敏感型亲水凝胶材料0.05-40％，其它药剂学上可接受的辅料0.01-50％。

USPTO Abstract

含有皮质激素和H1受体拮抗剂的鼻用原位凝胶，由作为有效成分由一种或几种皮质激素和一种或几种H1受体拮抗剂、环境敏感型亲水凝胶材料、其它药剂学上可接受的辅料以及余量的水制成，制剂的组分组成为：皮质激素0.01-1％，H1受体拮抗剂的含量为0.05％～1％，环境敏感型亲水凝胶材料0.05-40％，其它药剂学上可接受的辅料0.01-50％。

Drugs covered by this patent

Patent Metadata

Patent number
CN102078285A
Jurisdiction
CN
Classification
—
Expires
2011-06-01
Drug substance claim
No
Drug product claim
No
Assignee
Tianjin Jinyao Group Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.